ALLIANCE PHARMA

ALLIANCE PHARMA Share · GB0031030819 · 913253 (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ALLIANCE PHARMA
No Price
Share Float & Liquidity
Free Float 63,97 %
Shares Float 345,8 M
Shares Outstanding 540,57 M
Invested Funds

The following funds have invested in ALLIANCE PHARMA :

Fund
iShares MSCI UK Small Cap UCITS ETF GBP (Acc)
Vol. in million
667,22
Percentage (%)
0,11 %
Company Profile for ALLIANCE PHARMA Share
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Company Data

Name ALLIANCE PHARMA
Company Alliance Pharma plc
Website https://www.alliancepharmaceuticals.com
Primary Exchange XLON London
WKN 913253
ISIN GB0031030819
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Nicholas John Sedgwick
Market Capitalization 350 Mio
Country United Kingdom
Currency GBP
Employees 0,3 T
Address Avonbridge House, SN15 2BB Chippenham
IPO Date 2001-11-22
Dividends from 'ALLIANCE PHARMA '
Ex-Date Dividend per Share
22.06.2023 1,18 GBX
22.12.2022 0,59 GBX
09.06.2022 1,13 GBX
16.12.2021 0,56 GBX
10.06.2021 1,07 GBX
17.12.2020 0,54 GBX
19.12.2019 0,54 GBX
13.06.2019 0,98 GBX
20.12.2018 0,49 GBX
14.06.2018 0,89 GBX

Ticker Symbols

Name Symbol
Frankfurt DVL.F
London APH.L
More Shares
Investors who hold ALLIANCE PHARMA also have the following shares in their portfolio:
ATR.FIN.ISS. 21/27 MTN
ATR.FIN.ISS. 21/27 MTN Bond
INDEX TRACKER ZERTIFIKAT AUF SOLAR TOP 10 INDEX
INDEX TRACKER ZERTIFIKAT AUF SOLAR TOP 10 INDEX Zertifikat